Search research articles
Contact Us
Filters
Showing results (21-30 of 311) with videos related to
Page
of 32
Sort By:
Pathology
|
December 18, 2008
Current and future approach to the pathologist's assessment for targeted therapy in breast cancer
Pria Pakkiri, Sunil R Lakhani, Chanel E Smart
ANZ Journal of Surgery
|
January 9, 2014
Is the one-step nucleic acid amplification assay better for intra-operative assessment of breast sentinel nodes?
Mark Bettington, Sunil R Lakhani, Owen A Ung
Familial Cancer
|
June 26, 2010
The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers
Ana Cristina Vargas, Leonard Da Silva, Sunil R Lakhani
Journal of Visual Communication in Medicine
|
July 4, 2012
Simple techniques for three-dimensional photography of the nose in nasal deformity
M E Smith, R Lakhani, P Murray, et al.
Cancers
|
December 11, 2022
NDRG1 in Cancer: A Suppressor, Promoter, or Both?
Vaibhavi Joshi, Sunil R Lakhani, Amy E McCart Reed
Future Oncology (London, England)
|
March 17, 2009
Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact
Ana-Cristina Vargas, Sunil R Lakhani, Peter T Simpson
Expert Review of Anticancer Therapy
|
March 17, 2020
Pitfalls and controversies in pathology impacting breast cancer management
Woo Gyeong Kim, Margaret C Cummings, Sunil R Lakhani
Methods in Molecular Medicine
|
February 24, 2006
Expression profiling using cDNA microarrays
Chris Jones, Peter Simpson, Alan Mackay, et al.
Methods in Molecular Medicine
|
February 24, 2006
Gene expression analysis using filter cDNA microarrays
Peter Simpson, Chris Jones, Alan Mackay, et al.
Breast Cancer Research : BCR
|
March 30, 2010
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
Sunil R Lakhani, Kum Kum Khanna, Georgia Chenevix-Trench
Page
of 32
Search research articles
Search
Showing results (21-30 of 311) with videos related to
Sort By:
Page
of 32
Pathology
|
December 18, 2008
Current and future approach to the pathologist's assessment for targeted therapy in breast cancer
Pria Pakkiri, Sunil R Lakhani, Chanel E Smart
ANZ Journal of Surgery
|
January 9, 2014
Is the one-step nucleic acid amplification assay better for intra-operative assessment of breast sentinel nodes?
Mark Bettington, Sunil R Lakhani, Owen A Ung
Familial Cancer
|
June 26, 2010
The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers
Ana Cristina Vargas, Leonard Da Silva, Sunil R Lakhani
Journal of Visual Communication in Medicine
|
July 4, 2012
Simple techniques for three-dimensional photography of the nose in nasal deformity
M E Smith, R Lakhani, P Murray, et al.
Cancers
|
December 11, 2022
NDRG1 in Cancer: A Suppressor, Promoter, or Both?
Vaibhavi Joshi, Sunil R Lakhani, Amy E McCart Reed
Future Oncology (London, England)
|
March 17, 2009
Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact
Ana-Cristina Vargas, Sunil R Lakhani, Peter T Simpson
Expert Review of Anticancer Therapy
|
March 17, 2020
Pitfalls and controversies in pathology impacting breast cancer management
Woo Gyeong Kim, Margaret C Cummings, Sunil R Lakhani
Methods in Molecular Medicine
|
February 24, 2006
Expression profiling using cDNA microarrays
Chris Jones, Peter Simpson, Alan Mackay, et al.
Methods in Molecular Medicine
|
February 24, 2006
Gene expression analysis using filter cDNA microarrays
Peter Simpson, Chris Jones, Alan Mackay, et al.
Breast Cancer Research : BCR
|
March 30, 2010
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
Sunil R Lakhani, Kum Kum Khanna, Georgia Chenevix-Trench
Page
of 32